These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6109638)

  • 1. Increased renal neuroleptic binding in spontaneously hypertensive rats.
    Rosenblatt JE; Shore D; Wyatt RJ; Pert CB
    Eur J Pharmacol; 1980 Oct; 67(2-3):317-20. PubMed ID: 6109638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
    Nakajima T; Iwata K
    Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced [3H]spiroperidol binding in striatum of spontaneously hypertensive rat (SHR).
    Chiu P; Rajakumar G; Chiu S; Kwan CY; Mishra RK
    Eur J Pharmacol; 1982 Aug; 82(3-4):243-4. PubMed ID: 7128691
    [No Abstract]   [Full Text] [Related]  

  • 7. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site.
    Beart PM; Krstich M; McDonald D; Gundlach AL
    Neurosci Lett; 1982 Apr; 29(2):147-51. PubMed ID: 6123968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats.
    Bhargava HN
    Eur J Pharmacol; 1984 Apr; 100(1):109-12. PubMed ID: 6723774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro].
    Oelssner W; Peinhardt G; Büge A
    Pharmazie; 1985 May; 40(5):341-2. PubMed ID: 2863832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3H-spiroperidol binding sites in blood platelets.
    Khanna AS; Agrawal AK; Seth PK
    Biochem Biophys Res Commun; 1987 Aug; 146(3):983-8. PubMed ID: 3619946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3H-Spiroperidol labels dopamine receptors in pituitary and brain.
    Creese I; Schneider R; Snyder SH
    Eur J Pharmacol; 1977 Dec; 46(4):377-81. PubMed ID: 590345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors.
    Rosenfeld MR; Dvorkin B; Klein PN; Makman MH
    Brain Res; 1982 Mar; 235(1):205-11. PubMed ID: 6145486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species variation in dopamine receptor binding.
    Creese I; Stewart K; Snyder SH
    Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptors in bovine retina : characterization of the 3H-spiroperidol binding and its use for screening dopamine receptor affinity of drugs.
    Magistretti PJ; Schorderet M
    Life Sci; 1979 Nov; 25(19):1675-86. PubMed ID: 41997
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of [3H]zetidoline binding to rat striatal membranes.
    Barone D; Assandri A; Galliani G; Glässer A; Tarzia G
    J Pharm Pharmacol; 1985 Mar; 37(3):180-7. PubMed ID: 2858565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
    Andorn AC; Bacon BR; Nguyen-Hunh AT; Parlato SJ; Stitts JA
    Mol Pharmacol; 1988 Feb; 33(2):155-62. PubMed ID: 3340080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.